Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Feb 1;377(Pt 3):733–739. doi: 10.1042/BJ20031035

Adenosine transport in peripheral blood lymphocytes from Lesch-Nyhan patients.

Rosa J Torres 1, Isabel Deantonio 1, Carmen Prior 1, Juan G Puig 1
PMCID: PMC1223908  PMID: 14572307

Abstract

We postulated that adenosine function could be related to some of the neurological features of Lesch-Nyhan syndrome and therefore characterized adenosine transport in PBLs (peripheral blood lymphocytes) obtained from Lesch-Nyhan patients (PBL(LN)) and from controls (PBL(C)). Adenosine transport was significantly lower in PBL(LN) when compared with that in PBL(C) and a significantly lower number of high affinity sites for [(3)H]nitrobenzylthioinosine binding were quantified per cell ( B (max)) in PBL(LN) when compared with that in PBL(C). After incubation with 25 microM hypoxanthine, adenosine transport was significantly decreased in PBL(LN) with respect to PBL(C). Hypoxanthine incubation lowers [(3)H]nitrobenzylthioinosine binding in PBL(C), with respect to basal conditions, but does not affect it in PBL(LN). This indicates that hypoxanthine affects adenosine transport in control and hypoxanthine-guanine phosphoribosyltransferase-deficient cells by different mechanisms.

Full Text

The Full Text of this article is available as a PDF (131.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Khalidi U. A., Chaglassian T. H. The species distribution of xanthine oxidase. Biochem J. 1965 Oct;97(1):318–320. doi: 10.1042/bj0970318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allsop J., Watts R. W. Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development--their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome. J Neurol Sci. 1980 May;46(2):221–232. doi: 10.1016/0022-510x(80)90080-5. [DOI] [PubMed] [Google Scholar]
  3. Ballarín M., Fredholm B. B., Ambrosio S., Mahy N. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand. 1991 May;142(1):97–103. doi: 10.1111/j.1748-1716.1991.tb09133.x. [DOI] [PubMed] [Google Scholar]
  4. Brosh S., Boer P., Kupfer B., de Vries A., Sperling O. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency. J Clin Invest. 1976 Aug;58(2):289–297. doi: 10.1172/JCI108471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brosh S., Sperling O., Dantziger E., Sidi Y. Metabolism of guanine and guanine nucleotides in primary rat neuronal cultures. J Neurochem. 1992 Apr;58(4):1485–1490. doi: 10.1111/j.1471-4159.1992.tb11368.x. [DOI] [PubMed] [Google Scholar]
  6. Demirkiran M., Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995 Oct;38(4):571–579. doi: 10.1002/ana.410380405. [DOI] [PubMed] [Google Scholar]
  7. Dunwiddie T. V., Masino S. A. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001;24:31–55. doi: 10.1146/annurev.neuro.24.1.31. [DOI] [PubMed] [Google Scholar]
  8. Ernst M., Zametkin A. J., Matochik J. A., Pascualvaca D., Jons P. H., Hardy K., Hankerson J. G., Doudet D. J., Cohen R. M. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med. 1996 Jun 13;334(24):1568–1572. doi: 10.1056/NEJM199606133342403. [DOI] [PubMed] [Google Scholar]
  9. Ferrer I., Costell M., Grisolía S. Lesch-Nyhan syndrome-like behavior in rats from caffeine ingestion: changes in HGPRTase activity, urea and some nitrogen metabolism enzymes. FEBS Lett. 1982 May 17;141(2):275–278. doi: 10.1016/0014-5793(82)80065-3. [DOI] [PubMed] [Google Scholar]
  10. Ferré S., Fredholm B. B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 1997 Oct;20(10):482–487. doi: 10.1016/s0166-2236(97)01096-5. [DOI] [PubMed] [Google Scholar]
  11. Finger S., Heavens R. P., Sirinathsinghji D. J., Kuehn M. R., Dunnett S. B. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J Neurol Sci. 1988 Sep;86(2-3):203–213. doi: 10.1016/0022-510x(88)90099-8. [DOI] [PubMed] [Google Scholar]
  12. Howard W. J., Kerson L. A., Appel S. H. Synthesis de novo of purines in slices of rat brain and liver. J Neurochem. 1970 Jan;17(1):121–123. doi: 10.1111/j.1471-4159.1970.tb00509.x. [DOI] [PubMed] [Google Scholar]
  13. Jinnah H. A., Wojcik B. E., Hunt M., Narang N., Lee K. Y., Goldstein M., Wamsley J. K., Langlais P. J., Friedmann T. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci. 1994 Mar;14(3 Pt 1):1164–1175. doi: 10.1523/JNEUROSCI.14-03-01164.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Katsuragi T., Ushijima I., Furukawa T. The clonidine-induced self-injurious behavior of mice involves purinergic mechanisms. Pharmacol Biochem Behav. 1984 Jun;20(6):943–946. doi: 10.1016/0091-3057(84)90020-0. [DOI] [PubMed] [Google Scholar]
  15. LESCH M., NYHAN W. L. A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. Am J Med. 1964 Apr;36:561–570. doi: 10.1016/0002-9343(64)90104-4. [DOI] [PubMed] [Google Scholar]
  16. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 2001 Nov;79(3):463–484. doi: 10.1046/j.1471-4159.2001.00607.x. [DOI] [PubMed] [Google Scholar]
  17. Ledent C., Vaugeois J. M., Schiffmann S. N., Pedrazzini T., El Yacoubi M., Vanderhaeghen J. J., Costentin J., Heath J. K., Vassart G., Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature. 1997 Aug 14;388(6643):674–678. doi: 10.1038/41771. [DOI] [PubMed] [Google Scholar]
  18. Lee C. W., Jarvis S. M. Nucleoside transport in rat cerebral-cortical synaptosomes. Evidence for two types of nucleoside transporters. Biochem J. 1988 Jan 15;249(2):557–564. doi: 10.1042/bj2490557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lloyd H. G., Stone T. W. Chronic methylxanthine treatment in rats: a comparison of Wistar and Fischer 344 strains. Pharmacol Biochem Behav. 1981 Jun;14(6):827–830. doi: 10.1016/0091-3057(81)90368-3. [DOI] [PubMed] [Google Scholar]
  20. Lloyd K. G., Hornykiewicz O., Davidson L., Shannak K., Farley I., Goldstein M., Shibuya M., Kelley W. N., Fox I. H. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med. 1981 Nov 5;305(19):1106–1111. doi: 10.1056/NEJM198111053051902. [DOI] [PubMed] [Google Scholar]
  21. Markley H. G., Faillace L. A., Mezey E. Xanthine oxidase activity in rat brain. Biochim Biophys Acta. 1973 May 5;309(1):23–31. doi: 10.1016/0005-2744(73)90313-6. [DOI] [PubMed] [Google Scholar]
  22. Melani A., Corsi C., Giménez-Llort L., Martínez E., Ogren S. O., Pedata F., Ferré S. Effect of N-methyl-D-aspartate on motor activity and in vivo adenosine striatal outflow in the rat. Eur J Pharmacol. 1999 Nov 26;385(1):15–19. doi: 10.1016/s0014-2999(99)00729-3. [DOI] [PubMed] [Google Scholar]
  23. Miras-Portugal M. T., Torres M., Rotllan P., Aunis D. Adenosine transport in bovine chromaffin cells in culture. J Biol Chem. 1986 Feb 5;261(4):1712–1719. [PubMed] [Google Scholar]
  24. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  25. Newby A. C. How does dipyridamole elevate extracellular adenosine concentration? Predictions from a three-compartment model of adenosine formation and inactivation. Biochem J. 1986 Aug 1;237(3):845–851. doi: 10.1042/bj2370845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nyhan W. L., Wong D. F. New approaches to understanding Lesch-Nyhan disease. N Engl J Med. 1996 Jun 13;334(24):1602–1604. doi: 10.1056/NEJM199606133342411. [DOI] [PubMed] [Google Scholar]
  27. Park T. S., Gidday J. M. Effect of dipyridamole on cerebral extracellular adenosine level in vivo. J Cereb Blood Flow Metab. 1990 May;10(3):424–427. doi: 10.1038/jcbfm.1990.73. [DOI] [PubMed] [Google Scholar]
  28. Pastor-Anglada M., Casado F. J., Valdés R., Mata J., García-Manteiga J., Molina M. Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol. 2001 Jan-Mar;18(1):81–85. doi: 10.1080/096876800110033783. [DOI] [PubMed] [Google Scholar]
  29. Pelled D., Sperling O., Zoref-Shani E. Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from hypoxanthine-guanine phosphoribosyltransferase-deficient transgenic mice. J Neurochem. 1999 Mar;72(3):1139–1145. doi: 10.1046/j.1471-4159.1999.0721139.x. [DOI] [PubMed] [Google Scholar]
  30. Phillis J. W., O'Regan M. H., Walter G. A. Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex. Brain Res. 1989 Mar 6;481(2):309–316. doi: 10.1016/0006-8993(89)90808-1. [DOI] [PubMed] [Google Scholar]
  31. Puig J. G., Torres R. J., Mateos F. A., Ramos T. H., Arcas J. M., Buño A. S., O'Neill P. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine (Baltimore) 2001 Mar;80(2):102–112. doi: 10.1097/00005792-200103000-00003. [DOI] [PubMed] [Google Scholar]
  32. Rathbone M. P., Middlemiss P. J., Gysbers J. W., Andrew C., Herman M. A., Reed J. K., Ciccarelli R., Di Iorio P., Caciagli F. Trophic effects of purines in neurons and glial cells. Prog Neurobiol. 1999 Dec;59(6):663–690. doi: 10.1016/s0301-0082(99)00017-9. [DOI] [PubMed] [Google Scholar]
  33. Richter A., Hamann M., Bartling C. CGS 21680 exerts marked antidystonic effects in a genetic model of paroxysmal dyskinesia. Eur J Pharmacol. 2000 Sep 22;404(3):299–302. doi: 10.1016/s0014-2999(00)00627-0. [DOI] [PubMed] [Google Scholar]
  34. Rosenbloom F. M., Kelley W. N., Miller J., Henderson J. F., Seegmiller J. E. Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. JAMA. 1967 Oct 16;202(3):175–177. doi: 10.1001/jama.202.3.175. [DOI] [PubMed] [Google Scholar]
  35. Seegmiller J. E., Rosenbloom F. M., Kelley W. N. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science. 1967 Mar 31;155(3770):1682–1684. doi: 10.1126/science.155.3770.1682. [DOI] [PubMed] [Google Scholar]
  36. Soler C., Felipe A., Mata J. F., Casado F. J., Celada A., Pastor-Anglada M. Regulation of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis factor-alpha in human B-lymphocytes. J Biol Chem. 1998 Oct 9;273(41):26939–26945. doi: 10.1074/jbc.273.41.26939. [DOI] [PubMed] [Google Scholar]
  37. Torres M., Bader M. F., Aunis D., Miras-Portugal M. T. Nerve growth factor effect on adenosine transport in cultured chromaffin cells. J Neurochem. 1987 Jan;48(1):233–235. doi: 10.1111/j.1471-4159.1987.tb13152.x. [DOI] [PubMed] [Google Scholar]
  38. Torres M., Delicado E. G., Miras-Portugal M. T. Adenosine transporters in chromaffin cells: subcellular distribution and characterization. Biochim Biophys Acta. 1988 Apr 25;969(2):111–120. doi: 10.1016/0167-4889(88)90066-3. [DOI] [PubMed] [Google Scholar]
  39. Ushijima I., Katsuragi T., Furukawa T. Involvement of adenosine receptor activities in aggressive responses produced by clonidine in mice. Psychopharmacology (Berl) 1984;83(4):335–339. doi: 10.1007/BF00428541. [DOI] [PubMed] [Google Scholar]
  40. Watts R. W., Spellacy E., Gibbs D. A., Allsop J., McKeran R. O., Slavin G. E. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the Neurological manifestations. Q J Med. 1982;51(201):43–78. [PubMed] [Google Scholar]
  41. Wong D. F., Harris J. C., Naidu S., Yokoi F., Marenco S., Dannals R. F., Ravert H. T., Yaster M., Evans A., Rousset O. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5539–5543. doi: 10.1073/pnas.93.11.5539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zoref-Shani E., Bromberg Y., Brosh S., Sidi Y., Sperling O. Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line. J Neurochem. 1993 Aug;61(2):457–463. doi: 10.1111/j.1471-4159.1993.tb02146.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES